Industry Groups Need FDA Input On Antibacterial Ingredient Studies
This article was originally published in The Tan Sheet
Executive Summary
The Personal Care Products Council and American Cleaning Institute say industry needs FDA input on study designs and more time to study benzethonium and benzalkonium chloride in consumer antimicrobial wash products. FDA’s commitment under a 2013 consent decree to publish a monograph for triclosan use by September 2016 should not influence the GRASE status of other ingredients, the groups say.
You may also be interested in...
Here's The 'Rub' On Antiseptic Washes: FDA Wants Additional Safety, Efficacy Data
FDA says in a proposed rule that it currently does not intend to remove any products containing alcohol or benzalkonium from the market, but asks firms that want to continue marketing the products to submit additional GRAS/GRAE data on the ingredients.
Here's The 'Rub' On Antiseptic Washes: FDA Wants Additional Safety, Efficacy Data
FDA says in a proposed rule that it currently does not intend to remove any products containing alcohol or benzalkonium from the market, but asks firms that want to continue marketing the products to submit additional GRAS/GRAE data on the ingredients.
Cold Indication For Antihistamine Monograph Expected This Year – DNDP Director Michele
FDA this year will publish an antihistamine monograph rule stemming from a partnership with Canada, says Theresa Michele, director of the Division of Nonprescription Drug Products. At a recent CHPA conference, Michele suggested FDA will parlay strong momentum and internal improvements from 2015 into 2016 progress.